SLC34A2 and chronic kidney disease: Studies investigating the role for NaPi-IIb in bone health during CKD have shown that treatment of uremic NaPi-IIb−/− mice with sevelamer provides significant phosphate control and that this is associated with improvements in bone histomorphometric parameters [57].